Table 2.
RPB1 alleles | POLR2A (Human) | Individual with variant | YPD 30°C | YPD 37°C | SC-Leu MPA (20μg/ml) | YPD + Formamide (3%) | SC-Lys (Spt-) | YPRaf/Gal | SC-His |
---|---|---|---|---|---|---|---|---|---|
WT | WT | NA | + | + | MPAR | FormamideR | - | Gals | - |
Pro24Arg | Pro28Arg | 9 | -/+ | - | MPAR | FormamideS | - | Gals | - |
Glu26Val | Glu30Val | NA | + | + | MPAR | FormamideR | - | Gals | - |
Glu104His | Arg108His | 10 | + | +/- | MPAR | FormamideR | - | Gals | - |
Glu104Leu | Arg108Leu | NA | +/- | --/+ | MPAR | Weak FormamideS | - | Gals | - |
Arg134Trp | Arg140Trp | 11 | -/+ | - | MPAR | FormamideS | - | Gals | - |
Arg175Trp | Arg192Trp | NA | + | + | MPAR | FormamideR | - | Gals | - |
Gln313Cys | Arg327Cys | NA | + | + | MPAR | FormamideR | - | Gals | - |
Leu388Val | Leu402Val | NA | + | + | MPAR | FormamideR | - | Gals | - |
Asp423ΔIle424Δ | Asp437_Leu438del | NA | + | + | MPAR | Weak FormamideS | - | GalR | - |
Asp423Δ | Asp437del | NA | + | + | MPAR | Weak FormamideS | - | GalR | - |
Ile424Δ | Leu438del | 1 | + | + | MPAR | FormamideR | - | GalR | - |
Ala1069Val | Ala1092Val | 12 | + | + | MPAR | FormamideR | - | GalR | - |
Thr1272Ala | Thr1297Ala | NA | + | + | MPAR | FormamideR | - | Gals | -/+ |
Gly1388Arg | Gly1418Arg | 6 | + | + | MPAR | FormamideR | - | Slight GalR | - |
Gly1388Val | Gly1418Val | NA | + | + | MPAR | FormamideR | - | Slight GalR | - |
Table summarizing phenotypic analysis of potentially pathogenic POLR2A variants in yeast by spot assay (Figure 3). General (growth at standard propagation temperature on standard medium YPD 30°C) or conditional growth defects (YPD 37°C), YPD in presence of 3% formamide (a protein-folding stressor), or minimal media that enable detection of transcription-related phenotypes are shown: addition of drug mycophenolic acid (MPA) detecting defective IMD2 expression, medium lacking lysine (SC-Lys) for detection of altered transcription due to Suppressor of Ty phenotype (Spt-) at the lys2-128∂ reporter allele, rich medium YP with 2% raffinose and 1% galactose for detection of altered transcription apparent as suppression of the galactose toxicity (GalS) imposed by the gal10Δ56 reporter allele (YP Raf/Gal), medium lacking histidine for detection of altered transcription allowing constitutive expression of the imd2Δ::HIS3 transcriptional reporter (SC-His). Shaded cells indicate a phenotype different from WT, with darker shading indicating a stronger phenotype than lighter shading. Strength of growth is indicated as robust growth (+), reduced growth (+/−), weak growth (−/+), severe growth defect (−−/+), no growth (−).